Stanford
The South San Francisco-based startup recently published two studies showing the performance of its tests for predicting preterm birth and preeclampsia.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.
Metagenomic Infectious Disease Sequencing Test Repurposed for Cancer Detection From CSF Samples
Premium
The assay from a Stanford and UCSF team allows clinicians to scan for multiple cancers of the central nervous system and to reanalyze past samples.
Stanford Team Developing Metabolomic Technique to Detect Influzenza, Other Respiratory Viruses
Premium
Viruses can induce metabolite alterations that can be detected and allow for diagnosis of different infections, potentially including SARS-CoV-2.
Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection
Premium
The technology, developed by researchers at Stanford, showed strong performance in a new study of lymphoma, and early data for solid tumors is already available.